Great Point Partners as of March 31, 2015
Portfolio Holdings for Great Point Partners
Great Point Partners holds 32 positions in its portfolio as reported in the March 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Connecture | 25.1 | $57M | 5.5M | 10.35 | |
Hyperion Therapeutics | 10.1 | $23M | 500k | 45.90 | |
Vanda Pharmaceuticals (VNDA) | 5.7 | $13M | 1.4M | 9.30 | |
Orthofix International Nv Com Stk | 4.7 | $11M | 300k | 35.89 | |
Adamas Pharmaceuticals | 4.7 | $11M | 609k | 17.49 | |
Ocera Therapeutics | 4.1 | $9.2M | 2.0M | 4.71 | |
Alimera Sciences | 3.8 | $8.7M | 1.7M | 5.01 | |
Aurinia Pharmaceuticals (AUPH) | 3.7 | $8.5M | 1.9M | 4.38 | |
Derma Sciences Com Par $.01 | 3.6 | $8.3M | 978k | 8.47 | |
Vericel (VCEL) | 3.4 | $7.7M | 2.1M | 3.70 | |
Versartis | 3.1 | $7.1M | 385k | 18.37 | |
Sucampo Pharmaceuticals Cl A | 3.1 | $7.0M | 450k | 15.56 | |
D Stemline Therapeutics | 3.0 | $6.9M | 475k | 14.47 | |
Aradigm Corp Sponsored Adr | 2.8 | $6.3M | 1.0M | 6.32 | |
Ascendis Pharma A S (ASND) | 2.6 | $5.9M | 340k | 17.35 | |
Alcobra SHS | 2.4 | $5.5M | 984k | 5.63 | |
Dyax | 1.7 | $4.0M | 236k | 16.75 | |
Heron Therapeutics (HRTX) | 1.7 | $3.9M | 270k | 14.55 | |
Tenax Therapeutics | 1.6 | $3.6M | 1.1M | 3.26 | |
Ampio Pharmaceuticals Put Option | 1.4 | $3.2M | 422k | 7.53 | |
Enanta Pharmaceuticals (ENTA) | 1.3 | $3.1M | 100k | 30.62 | |
Emergent BioSolutions (EBS) | 1.3 | $3.0M | 103k | 28.76 | |
Athersys Call Option | 1.2 | $2.7M | 930k | 2.89 | |
Sunesis Pharmaceuticals Com New | 1.1 | $2.5M | 1.0M | 2.45 | |
Mela Sciences Com New | 0.6 | $1.5M | 570k | 2.57 | |
Bellicum Pharma | 0.5 | $1.2M | 50k | 23.18 | |
Bovie Medical Corporation | 0.5 | $1.1M | 480k | 2.39 | |
Vical Incorporated | 0.4 | $800k | 847k | 0.94 | |
Streamline Health Solutions (STRM) | 0.2 | $538k | 152k | 3.55 | |
Veracyte (VCYT) | 0.2 | $497k | 68k | 7.29 | |
Osiris Therapeutics | 0.1 | $214k | 12k | 17.59 | |
Mei Pharma Com New | 0.0 | $94k | 52k | 1.80 |